Comparison

Atabecestat European Partner

Item no. M10943-5mg
Manufacturer AbMole
CASRN 1200493-78-2
Amount 5mg
Category
Type Chemicals
Specific against other
Purity >98.5%
Formula C18H14FN5OS
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias JNJ-54861911
Available
Target Information
BACE
Molecular Weight
367, 4
Solubility
DMSO ≥ 200 mg/mL
Bioactivity information
Atabecestat (JNJ-54861911) is a potent brain-osmotic and has oral activity β-position amyloid precursor protein lyase 1 (BACE1 inhibitors that strongly reduce the expression of Aβ protein in cerebrospinal fluid. Atabecestat (JNJ-54861911) is tolerant and has sustained pharmacokinetic (PK) and pharmacodynamic (PD) profiles. Atabecestat (JNJ-54861911) has the potential to be used in the study of Alzheimer's disease.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close